AIM Delisting and Admission to the Standard Listing Segment of Main Market
Tiziana Life Sciences plc (TILS.Nasdaq.L) AIM Delisting and Admission to Main Market
Tiziana Life Sci Plc (TILS.L) Appointment of Chief Medical Officer
Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer
Tiziana Life Sci PLC (TILS.L) to Present at Biotech Showcase Digital 2021
NEW YORK and LONDON – 11 January 2021 (GLOBE NEWSWIRE) – Tiziana Life Sciences plc (NASDAQ: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative
Tiziana Life Sci PLC (TILS.L) Completion of Foralumab Clinical Trial in Brazil
Tiziana announces completion of the clinical trial with nasally administered Foralumab, its proprietary fully human anti-CD3 monoclonal antibody, for the treatment of COVID-19 patients in Brazil
Share Talk Weekly Stock Market News, Sunday 15th November 2020
Share Talk is proud to be hosting a Webinar with Amur Minerals on Wednesday, November 25, 2020 · 04:00:00 PM · London Time.
Tiziana Life Sci PLC (TILS.L) Phase 1b/2 Clinical Trial – Crohn’s Disease
Phase 1b/2 Clinical Trial – Crohn’s Disease
Tiziana Life Sci PLC (TILS.L) Initiation of Clinical Trial for COVID-19 Patients
Tiziana Announces Initiation of Clinical Trial for COVID-19 Patients in Brazil with Nasally Administered Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody
Share Talk Weekly Stock Market News, Sunday 1st November 2020
After investing heavily in our RNS delivery infrastructure over the last two years we are super proud to announce on our 150th weekly market issue that our tests have shown
Tiziana Life Sci (TILS.L) Exercise of options, Issue of Equity, PDMR Dealing
London, New York, 26 October 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation
Tiziana Life Sci PLC (TILS.L) Exercise of Options, Issue of Equity, PDMR Dealing
London, New York, 21 October 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation
TIZIANA LIFE SCI PLC (TILS.L) Result of General Meeting
At the General Meeting of the Company held at 11.00 a.m. on 2 October 2020, both of the resolutions were duly passed.
